 |
25.09.2008
BrainsGate launches ImPACT-24
ImPACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window read more |
 |
20.02.2008
AHA Stroke conference
BrainsGate launches its pivotal trial, ImpACT-24 in New Orleans read more |
 |
06.06.2007
BioMed 2007
BrainsGate attends BioMed 2007 in Tel-Aviv read more |
 |
29.05.2006
BioMed 2006
BrainsGate attends BioMed 2006 in Jerusalem read more |
 |
09.04.2006
Bio 2006
BrainsGate attends Bio 2006 in Chicago read more |
 |
16.02.2006
International Stroke meeting 2006
BrainsGate attended and presented a poster read more |
|
September 25, 2008
BrainsGate launches ImPACT-24
ImPACT-24 is a randomized, sham-controlled, double blind study to test the safety and efficacy of BrainsGate's ISS for treatment of acute ischemic stroke victims in a 24 hour window > full story
August 13, 2008
BrainsGate raises $27.5m
This is the first investment in Israel in over a year by Johnson & Johnson's VC arm.
by Gali Weinreb > full story
|
Login
